Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


Background

Despite the potential benefits of protective ileostomy in rectal surgery, diverting loop ileostomy construction is not free of specific medical consequences implying unplanned hospital readmissions. The most common reason for readmission in these patients is a dehydration with a prevalence of acute renal failure (ARF) of 20%. The objective of this study was to establish the predictive factors of ARF in patients with protective ileostomy after surgery for rectal cancer from a bicentric study.

Methods

we conducted a bicentric retrospective cohort study to identify the risk factor of ARF. This study was carried out on 277 patients operated for rectal cancer with necessity of a protective ileostomy during the study period. ARF was measured at any endpoint between ileostomy creation and reversal. Multiple logistic regressions were performed to identify independent risk factors.

Results

A total of 277 patients were included, and 18% (n = 50) were readmitted for ARF. In multivariate logistic regression, increased age (OR 1.02, p = 0.01), Psychiatric diseases (OR 4.33, p = 0.014), Angiotensin II receptor blockers (OR 5.15, p < 0.001) and the ASA score ≥ 3 (OR 9.5, p < 0.001) were significantly associated with ARF.

Conclusion

Acute renal failure is a prevalent and significant event in the postoperative course of ileostomy patients. Patients at risk should be risk stratified before discharge and targeted for intensive preventive measures.

Free full text 


Logo of bmcsurgBioMed Central web sitethis articleSearchManuscript submissionRegistrationJournal front page
BMC Surg. 2023; 23: 107.
Published online 2023 Apr 28. https://doi.org/10.1186/s12893-023-02016-4
PMCID: PMC10148495
PMID: 37118719

Risk factors of acute renal failure in patients with protective ileostomy after rectal cancer surgery

Associated Data

Data Availability Statement

Abstract

Background

Despite the potential benefits of protective ileostomy in rectal surgery, diverting loop ileostomy construction is not free of specific medical consequences implying unplanned hospital readmissions. The most common reason for readmission in these patients is a dehydration with a prevalence of acute renal failure (ARF) of 20%. The objective of this study was to establish the predictive factors of ARF in patients with protective ileostomy after surgery for rectal cancer from a bicentric study.

Methods

we conducted a bicentric retrospective cohort study to identify the risk factor of ARF. This study was carried out on 277 patients operated for rectal cancer with necessity of a protective ileostomy during the study period. ARF was measured at any endpoint between ileostomy creation and reversal. Multiple logistic regressions were performed to identify independent risk factors.

Results

A total of 277 patients were included, and 18% (n = 50) were readmitted for ARF. In multivariate logistic regression, increased age (OR 1.02, p = 0.01), Psychiatric diseases (OR 4.33, p = 0.014), Angiotensin II receptor blockers (OR 5.15, p < 0.001) and the ASA score  3 (OR 9.5, p < 0.001) were significantly associated with ARF.

Conclusion

Acute renal failure is a prevalent and significant event in the postoperative course of ileostomy patients. Patients at risk should be risk stratified before discharge and targeted for intensive preventive measures.

Keywords: Rectal cancer, Protective ileostomy, Risk factors, Acute renal failure

Introduction

Colorectal cancer (CRC) is already the third leading cause of cancer death in the world, and its incidence is steadily rising in developing nations. The CRC is more incident among men than women and 3–4 times more common in developed than in developing nations. [1]

Surgery is the major treatment modality and is often supplemented by preoperative neoadjuvant radiotherapy and chemotherapy or postoperative adjuvant chemotherapy. [2]

Anterior resection of rectal cancer is the major anal-preservation operation. However, anastomotic leakage is one of the most important surgical complications of colorectal surgery, and it has been of great concern due to high occurrence of morbidity and mortality. The proximal diversion, either by a colostomy or an ileostomy, by preventing fecal flow through the anastomosis, minimizes the consequences of the anastomotic leak. [3]

The current trend favors protective ileostomies rather than colostomies in the protection of colorectal anastomose [4]; However, protective loop ileostomy was found to be associated with a high morbidity. In addition to local complications, the presence of an ileostomy “short-circuits” colic stool dehydration resulting in chronic water and sodium depletion. It is therefore not surprisingly, that the most common reason for readmission in these patients is a dehydration with a prevalence of acute renal failure (ARF) of 20% [510].

In order to establish strategies for the prevention of ARF within those patients it is necessary to determine the risk factors.

The objective of this study is to establish the predictive factors of ARF in patients with protective ileostomy after surgery for rectal cancer from a bicentric study.

Methods

We carried out a bicentric retrospective cohort study, performed at the department of general surgery and digestive oncology of the university hospital of l’Archet 2 (Nice, France) and the department of general surgery of the university hospital Hassan II (Fez, Morocco).

Patients undergoing surgeries from January 2009 to December 2019 in the university hospital l’Archet 2 and from January 2015 to December 2020 in the university hospital Hassan II were retrospectively identified from the surgical act’s archives. Patients undergoing elective rectal resection with primary anastomosis and formation of a protective ileostomy were included in the study. Exclusion criteria were: pathology other than rectal adenocarcinoma, sigmoid colonic cancer and palliative loop ileostomy.

ARF, defined by the Acute Kidney Injury Network (AKIN) [8], was measured at any endpoint (outpatient consultation, readmission in surgery, emergency or acute care unit) between ileostomy creation and reversal.

Baseline data collected included: age, sex, cardiovascular risk factors and cardiovascular diseases, chronic alcoholism, chronic smoking, renal disease (defined as any nephropathy with or without decreased glomerular filtration rate), respiratory disease (asthma, chronic obstructive pulmonary disease, pulmonary tuberculosis), psychiatric diseases (dementia, depressive disorder), and long-term medication use. The ASA score, a comorbidity classification associated with post-operative morbidity and the Clavien-Dindo complication scoring system, classifying postoperative complications based on therapy required were calculated for each patient. Other variables such as neoadjuvant treatment, surgical approach and season of the procedure were collected.

Statistical analysis

The data was stratified based on whether the patient presented ARF in the follow up.

The data were entered and coded on Excel, the statistical analysis was done in two steps.

 1st step: We performed a descriptive analysis of the collected data. The results were presented in the form of percentages for the qualitative variables and means ± standard deviation for the quantitative variables.

 2nd step: univariate analysis was used to determine the factors associated with acute renal failure using the Student and Chi 2 statistical tests then a multivariate analysis using stepwise multiple logistic regression was performed. The independent variables for the model were selected from univariate analysis based on a threshold p-value of 0.20. The results are reported in commented tables. A p < 0.05 was considered significant.

Results

We report in this study 277 patients operated for rectal cancer with necessity of a protective ileostomy during the study period. 159 (57%) were male and the median age was 60.95 years ± 12.48 (range between 27 and 90 years). 50 of 277 patients (18%) were readmitted for ARF during their follow-up period prior to the stoma closure.

Diabetes and high blood pressure were the most common comorbidities within our patients, respectively 14.1% and 27.1%. Table 1.

Table 1

Comorbidities of the population in the study

ComorbiditiesNumberPercentage
Diabetes3914.1
High blood pressure7527.1
Cardiovascular diseases248.7
Respiratory diseases186.5
Psychiatric diseases186.5
Renal diseases82.9
Chronic alcoholism3713.4
Chronic smoking5820.9
Dyslipidemia3412.3

Two hundred thirty-three of our patients (84.1%) had an ASA score < 3. Neo adjuvant treatment either by radio-chemotherapy or exclusive radiotherapy was initiated in 238(85.9%) of our patients. A laparoscopic approach was used in184(66.4%) of our patients and a laparotomy in 93(33.6%) of patients. 62 (22.5%) of our patients presented postoperative complications classified according to the Clavien-Dindo classification (Table 2).

Table 2

Post operative complications according to the Clavien-Dindo classification

Complications: Clavien-Dindo classificationNumberPercentage
All grades6222.5
Grade 1279.7
Grade 2124.4
Grade 3238.4

Seventy-four of our patients (26.7%) were operated in autumn, 74 (26.7%) in winter, 90 (32.5%) in spring and 39 (14.1%) in summer.

Among the 55 patients readmitted for ARF, 15 patients (30%) progressed to chronic kidney disease and 4 patients (8%) have died.

Univariate analysis identified increased age, high blood pressure, diabetes, renal diseases, psychiatric diseases (dementia, depressive disorder), medications (diuretics, angiotensin II receptor blockers and ACE inhibitors) and ASA score  3 were significantly associated with an ARF in the follow up course. Table 3.

Table 3

Summary of the univariate analysis

All patients
N = 277
Acute renal failure
N = 50(18.0%)
No acute renal failure
N = 227(82.0%)
P
Sex P = 0.345

M

F

159(57.4%)

118(42.6%)

32(64.0%)

18(36.0%)

127(55.9%)

100(44.1%)

Median age 60.95 ± 12.4868.50 ± 12.1759.29 ± 11.95P = 0.001
Comorbidities

High blood pressure

Diabetes

Chronic smoking

Dyslipidemia

75(27.1%)

39(14.1%)

58(20.9%)

34(12.3%)

27(54.0%)

14(28.0%)

12(24.0%)

9(18.0%)

48(21.1%)

25(11.0%)

46(20.3%)

25(11.0%)

P = 0.001

P = 0.003

P = 0.756

P = 0.231

Chronic alcoholism37(13.4%)4(8.0%)33(14.5%)P = 0.259
Psychiatric disease18(6.5%)8(16.0%)10(4.4%)P = 0.007
Cardiovascular diseases24(8.7%)8(16.0%)16(7.0%)P = 0.082
Respiratory disease18(6.5%)4(8.0%)14(6.2%)P = 0.750
Renal disease8(2.9%)4(8.0%)4(1.8%)P = 0.038
Treatment

diuretics

ACE inhibitors

Calcium channel blockers

angiotensin II receptor blockers

26(9.4%)

27(9.7%)

20(7.2%)

33(11.9%)

9(18.0%)

12(24.0%)

5(10.0%)

18(36.0%)

17(7.5%)

15(6.6%)

15(6.6%)

15(6.6%)

P = 0.037

P = 0.001

P = 0.545

P = 0.001

ASA score P = 0.001

< 3

 3

233(84.1%)

44(15.9%)

24(48.0%)

26(52.0%)

209(92.1%)

18(7.9%)

Neo adjuvant treatment 238(85.9%)45(90%)193(85%)P = 0.386
Surgery P = 0.741

Coelioscopic approach

Laparotomy approach

184(66.4%)

93(33.6%)

32(64.0%)

18(36.0%)

152(67.0%)

75(33.0%)

Post operative complications P = 0.365
Clavien-Dindo classification

 1

 2

 3

27(9.7%)

12(4.4%)

23(8.4%)

4(8.0%)

2(4.0%)

5(10.0%)

23(10.2%)

10(4.4%)

18(7.9%)

Season of the procedure P = 0.280

Autumn

Winter

Spring

Summer

74 (26,7%)

74 (26,7%)

90 (32,5%)

39 (14,1%)

12(24,0%)

10(20,0%)

22(44,0%)

6(12,0%)

62(27,3%)

64(28,2%)

68(30,0%)

33(14,5%)

In multivariate analysis, increased age, the ASA score, psychiatric diseases and ARA 2 were independently associated with an acute renal failure. Table 4.

Table 4

Multiple Logistic Regression Results

OR95% CIP
Age1.020.98–1.05P = 0.01
Psychiatric disease P = 0.014

 No

 yes

1

4.33

1

1.34-14.00

Angiotensin II receptor blockers P < 0.001

 No

 Yes

1

5.15

1

2.08–12.74

ASA score P < 0.001

 < 3

  3

1

9.50

1

4.32–20.87

Discussion

The objective of this study was to establish the predictive factors of acute renal failure in patients with protective ileostomy after surgery for rectal cancer in order to establish strategies for the prevention of patients at risk.

This study is, to our knowledge, one of the few cohorts studying the risk factors for the occurrence of renal failure after protective ileostomy for rectal cancer surgery.

The question has been treated in a different way by other researchers. Some have focused on readmission rates and the impact of ileostomy on kidney function [1114].

The results of this study reinforce the findings of previous studies. Thus, our acute renal failure rate was 18%, a rate close to those of Gessler et al. [15] (21%) and Beck-Kaltenbach et al. [7] (30%).

The univariate analysis showed that increased age, high blood pressure, diabetes, renal diseases, psychiatric diseases (dementia, depressive disorder), medications (diuretics, angiotensin II receptor blockers and ACE inhibitors) and ASA score  3 were significantly associated with an acute renal failure. After the multivariate analysis, only increased age, ASA score, psychiatric diseases and angiotensin II receptor blockers were independently associated with an acute renal failure.

Age was the most identified risk factor responsible for acute renal failure in the literature as reported by Gessler [15] in his series published in 2014, paquette [11] in his series published in 2013 and Fiedeling [13] in his series published in 2020. For high blood pressure, only one study in the literature, that of Gessler [15], has shown its involvement in the occurrence of acute renal failure. In our study, high blood pressure did not reach the significance threshold. The use of antihypertensive drugs can be a source of readmission for ARF. This concerns ARA2, reported by Fiedeling [13] and diuretics reported by Messaris [5]. In our study, angiotensin II receptor blockers were significantly associated with readmissions for ARF. However, psychiatric diseases (dementia, depressive disorder) and an ASA score  3 represent to our knowledge new findings in the literature.

The season of the operative act, a variable studied for the first time in the literature to our knowledge, was studied to investigate whether the higher incidence of dehydration during summer months could exacerbate kidney damage but it was not associated with ARF in our research.

It should be highlighted that ARF is a serious condition that can have severe consequences for patients. Our study showed that among the 55 patients who were readmitted for ARF, 15 patients (30%) progressed to chronic kidney disease and 4 patients (8%) died. We did not find any data in the literature regarding the evolution of patients with ARF due to an ileostomy.

This study has multiple clinical implications, it will allow us to reinforce the attention needed for patients with ileostomies in their postoperative course both inside and outside the hospital and to establish prevention measures for high-risk patients and therefore it will allow us to improve the outcomes in this population.

Limitations of our study include the retrospective nature of the study and the fact that we did not measure ileostomy output or collect data about the use of loperamide; however, this study is one of the few cohorts studying the risk factors for the occurrence of renal failure after protective ileostomy for rectal cancer surgery.

Conclusion

Acute renal failure is a prevalent and significant event in the postoperative course of ileostomy patients occurring in 18% of them. The causes are heterogeneous, but the most influential predictive factors appear to be the age, ASA score, psychiatric diseases, and use of ARA2. Patients at risk should be risk stratified before discharge and targeted for intensive preventive measures fighting dehydration; high stoma output and low water and electrolytes input.

Acknowledgements

Not applicable.

List of Abbreviations

ACEAngiotensin-Converting Enzyme
AKINAcute Kidney Injury Network
ARFAcute renal failure
ASAAmerican Society of Anesthesiologists
CRCColorectal cancer

Authors’ contributions

Benjelloun El Bachir, Benizri Emmanuel, Marghich Omar, Rahili Mohamed Amine, Mazaz Khalid, Mouaquit ouadii, El Bhouaddouti Hicham, Ait Taleb Khalid, Efoé-Ga Yawod Olivier Amouzou and Bouassria Abdeslam have conceived and coordinated the study. Benizri Emmanuel have done the design of the study. Marghich Omar and Anis Tarek have done the data collection. Marghich Omar has done the interpretation of the data and the redaction of the manuscript. Benizri Emmanuel and Benjelloun El Bachir have corrected the manuscript. All authors read and approved the final manuscript.

Funding

The authors received no specific funding for this study.

Data Availability

All data generated or analyzed during this study are included in this published article.

Declarations

Ethics approval and consent to participate

The local institutional review board of surgery at the university hospital Hassan II of Fez and the university hospital l’Archet 2 of Nice had approved this retrospective study and also gave its approval to waive the patients informed consent with the emphasis on patient’s confidentiality.

All methods used in this study were carried out in accordance with relevant guidelines and regulations and approved by the head of the division of abdominal surgery in the university hospital Hassan II of Fes, Morocco and the university hospital l’Archet 2 of Nice, France.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

1. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14:89–103. [Europe PMC free article] [Abstract] [Google Scholar]
2. Gérard J-P, et al. Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) Dig Liver Dis. 2017;49:359–367. 10.1016/j.dld.2017.01.152. [Abstract] [CrossRef] [Google Scholar]
3. Matthiessen P, Hallböök O, Rutegård J, Simert G, Sjödahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg. 2007;246:207–214. 10.1097/SLA.0b013e3180603024. [Abstract] [CrossRef] [Google Scholar]
4. Rondelli F, et al. Loop ileostomy versus loop colostomy for fecal diversion after colorectal or coloanal anastomosis: a meta-analysis. Int J Colorectal Dis. 2009;24:479–488. 10.1007/s00384-009-0662-x. [Abstract] [CrossRef] [Google Scholar]
5. Messaris E, et al. Dehydration is the most common indication for readmission after diverting ileostomy creation. Dis Colon Rectum. 2012;55:175–180. 10.1097/DCR.0b013e31823d0ec5. [Abstract] [CrossRef] [Google Scholar]
6. Stoma complications: a literature overview - Shabbir – 2010 - Colorectal Disease - Wiley Online Library. https://onlinelibrary.wiley.com/doi/10.1111/j.1463-1318.2009.02006.x [Abstract]
7. Beck-Kaltenbach N, Voigt K, Rumstadt B. Renal impairment caused by temporary loop ileostomy. Int J Colorectal Dis. 2011;26:623–626. 10.1007/s00384-010-1086-3. [Abstract] [CrossRef] [Google Scholar]
8. Hilton R. Defining acute renal failure. CMAJ. 2011;183:1167–1169. 10.1503/cmaj.081170. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
9. Güenaga, K. F., Lustosa, S. a. S., Saad, S. S., Saconato, H. & Matos, D. Ileostomy or colostomy for temporary decompression of colorectal anastomosis. Cochrane Database Syst Rev CD004647 (2007) 10.1002/14651858.CD004647.pub2 [Europe PMC free article] [Abstract]
10. Tilney, H. S. et al. Comparison of outcomes following ileostomy versus colostomy for defunctioning colorectal anastomoses. Database of abstracts of reviews of Effects (DARE): Quality-assessed Reviews [Internet] (Centre for Reviews and Dissemination (UK), 2007). [Abstract]
11. Paquette IM, Solan P, Rafferty JF, Ferguson MA, Davis BR. Readmission for dehydration or renal failure after ileostomy creation. Dis Colon Rectum. 2013;56:974–979. 10.1097/DCR.0b013e31828d02ba. [Abstract] [CrossRef] [Google Scholar]
12. Li L, et al. Ileostomy creation in colorectal cancer surgery: risk of acute kidney injury and chronic kidney disease. J Surg Res. 2017;210:204–212. 10.1016/j.jss.2016.11.039. [Abstract] [CrossRef] [Google Scholar]
13. Fielding A, et al. Renal impairment after ileostomy formation: a frequent event with long-term consequences. Colorectal Dis. 2020;22:269–278. 10.1111/codi.14866. [Abstract] [CrossRef] [Google Scholar]
14. Smith SA, et al. New ileostomy formation and subsequent community-onset Acute and chronic kidney disease: a Population-based Cohort Study. Ann Surg. 2021;274:352–358. 10.1097/SLA.0000000000003617. [Abstract] [CrossRef] [Google Scholar]
15. Gessler B, Haglind E, Angenete E. A temporary loop ileostomy affects renal function. Int J Colorectal Dis. 2014;29:1131–1135. 10.1007/s00384-014-1949-0. [Abstract] [CrossRef] [Google Scholar]

Articles from BMC Surgery are provided here courtesy of BMC

Citations & impact 


Impact metrics

Jump to Citations

Article citations